Avaliação da agregação plaquetária em presença de anticorpos antifosfolípides: anti-β2GP1 e anticardiolipina

Visseaux, 2011, Antiphospholipid syndrome diagnosis: an update, Annales de Biologie Clinique, 69, 411, 10.1684/abc.2011.0592 Sá, 2011, Gangrene of the auricle as the first signo f antiphospholipid antibody syndrome, Rev Bras Reumatol, 51, 655 Miyakis, 2006, Internacional consensus statement on an update of the classification criteria for definite antiphospholipid sindrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Sangle, 2011, Antiphospholipid antibody syndrome, Arch Pathol Lab Med, 135, 1092, 10.5858/2010-0325-RSR.1 Perches, 2011, Avaliação da pesquisa de anticorpos antifosfolipídios para o diagnóstico da síndrome antifosfolípide, Rev Bras Reumatol, 51, 236 Ranzolin, 2004, Anticorpos contra beta2-glicoproteína I, autoimunidade e aterosclerose, Rev Bras Reumatol, 44, 139, 10.1590/S0482-50042004000200006 Santos, 2007, Síndrome antifosfolípide:uma causa de neuropaita periférica?, Rev Bras Reumatol, 47, 281, 10.1590/S0482-50042007000400007 Rizzatti, 2001, Tratamento do tromboembolismo venoso, Medicina, Ribeirão Preto, 34, 269, 10.11606/issn.2176-7262.v34i3/4p269-275 Pengo, 2009, Update of the guidelines for lupus anticoagulant detection, J Thromb Haemost, 7, 1737, 10.1111/j.1538-7836.2009.03555.x Villalta, 2009, Accuracy of the First Fully Automated Method for Anticardiolipin and Anti-β2 Glycoprotein I Antibody Detection for the Diagnosis of Antiphospholipid Syndrome, Ann NY Acad Sci, 1173, 21, 10.1111/j.1749-6632.2009.04659.x Cavalcante, 2000, Influência da cafeína no comportamento da pressão arterial e da agregação plaquetária, Arq Bras Cardiol, 75, 97 Erkan, 2006, Antiphospholipid syndrome, Curr Opin Rheumatol, 18, 242, 10.1097/01.bor.0000218943.89365.13 Arnout, 2003, Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease, J Thromb Haemost, 1, 931, 10.1046/j.1538-7836.2003.00125.x Nimmo, 2003, The antiphospholipid antibody syndrome a riddle wrapped in a mystery inside an enigma, Clinical and Applied Immunology Rev, 4, 125, 10.1016/S1529-1049(03)00047-3 Santamaria, 2005, Síndrome antifosfolípide, An Bras Dermatol, 3, 225, 10.1590/S0365-05962005000300002 Shi, 2006, Anti-β2-glycoproteína I antibodies in complex with β2- glycoproteína I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V, Arthritis Rheum, 54, 2558, 10.1002/art.21968 Cabral, 2004, Heterogeneity of antibodies to β2-glycoprotein 1 from patients with systemic lupus erithematosus, Lupus, 13, 182, 10.1191/0961203303lu531oa Cuadrado, 2003, Antiphospholipid syndrome, Clin Exp Med., 3, 129, 10.1007/s10238-003-0016-x Levine, 2002, The Antiphospholipid syndrome, N Engl J Med, 346, 752, 10.1056/NEJMra002974 Bas De Laat, 2004, β2-glicoproteína I, the playmaker of the antiphospholipid syndrome, Clinical Immunology, 112, 161, 10.1016/j.clim.2004.02.012 Palatinus, 2012, Effects of antiphospholipid antibodieson in vitro platelet aggregation, Clin Appl Thromb Hemost, 18, 59, 10.1177/1076029611412360 Marai, 2004, The systemic nature of the antiphospholipid syndrome, Scand j Rheumatol, 33, 365, 10.1080/03009740410010290 Galli, 2003, Antiphospholipid syndrome: association between laboratory tests and clinical practice, Pathophysiol Haemost Thromb, 33, 249, 10.1159/000083810